Biotech Firm Coming To Pearland

Lonza Group, a massive Swiss pharmaceutical company, plans to build a 100k SF biotech facility in Pearland that will replace Lonza’s existing Houston operations. The new facility will be on an 11-acre plot in Pearland’s Lower Kirby District.

The Pearland Economic Development Council and Lonza have been in discussions since 2014, according to the Houston Business Journal. Fort Worth-based Rogue Architects is the architect of record.

The new facility will have 100k SF of office space, labs and other areas that will facilitate the production of its viral gene and virally modified therapeutics. [HBJ]

Continue reading this story with a free account

Log in or register
Sign up for more articles like this
Subscribe to Bisnow's Houston Newsletters
Related Stories

Formation Breaks Ground On 673K SF Industrial Park: The Houston Deal Sheet

ERock Moving HQ With 72K SF Lease At Central Park Post Oak

DFW Industrial Growth Expands Beyond Core Markets As Developers Chase Cheaper Land

Triten Starts Speculative, Small-Bay Industrial Project

Moody National Tops Out On Apartment Complex At Historic Silo Development

Energy Company Leases 26K SF At Newly Acquired Office: The Houston Deal Sheet

Waymo Reportedly Planning 200K SF South Philly Warehouse

Shallow-Bay Industrial Is In Demand But Hard To Build. Here's How One Philly Developer Made It Work

Insurance Pricing Piles Pressure On Houston's Older Apartments

EXCLUSIVE: Glenstar Taps Industry Vet As It Plots Expansion Of Logistics Arm

Developers Launch 900K SF Of Industrial, Manufacturing Projects In Houston

Power Scarcity Poses Problems For Charlotte Industrial Developers